Advancements in manganese complex-based MRI agents: Innovations, design strategies, and future directions
Shubham Roy,
No information about this author
Jingsi Gu,
No information about this author
Wujiong Xia
No information about this author
et al.
Drug Discovery Today,
Journal Year:
2024,
Volume and Issue:
29(9), P. 104101 - 104101
Published: July 16, 2024
Language: Английский
Large-Scale Synthesis of Non-Ionic Bismuth Chelate for Computed Tomography Imaging in Vivo
Biomaterials,
Journal Year:
2025,
Volume and Issue:
318, P. 123122 - 123122
Published: Jan. 24, 2025
Language: Английский
Innovations in Quantitative Rapid Testing: Early Prediction of Health Risks
Khaled S Alleilem,
No information about this author
Saad Almousa,
No information about this author
Mohammed Alissa
No information about this author
et al.
Current Problems in Cardiology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103000 - 103000
Published: Feb. 1, 2025
Language: Английский
Hybrid Sensor Integration in Wearable Devices for Improved Cardiovascular Health Monitoring
Bangul Khan,
No information about this author
Waqar Ahmad Khan,
No information about this author
M. Abul Masrur
No information about this author
et al.
Journal of Science Advanced Materials and Devices,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100889 - 100889
Published: April 1, 2025
Language: Английский
Imaging technology in tracking the intravital fate of transplanted stem cells
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107752 - 107752
Published: April 1, 2025
Language: Английский
Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging
Zhongyuan Cai,
No information about this author
Lingling Jiang,
No information about this author
Yingzi Cao
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(6), P. 5011 - 5031
Published: March 7, 2024
Effective
vascular
and
hepatic
enhancement
better
safety
are
the
key
drivers
for
exploring
gadolinium-free
hepatobiliary
contrast
agents.
Herein,
a
facile
strategy
proposes
that
high
lipophilicity
may
be
favorable
to
enhancing
sequentially
signal
intensity
based
on
structure–activity
relationship
both
uptake
interaction
with
serum
albumins
partly
depend
lipophilicity.
Therefore,
11
newly
synthesized
derivatives
of
manganese
o-phenylenediamine-N,N,N′,N′-tetraacetic
acid
(MnLs)
were
evaluated
as
The
maximum
intensities
heart,
liver,
kidneys
strongly
correlated
log
P,
indicator
most
lipophilic
agent,
MnL6,
showed
relaxivity
when
binding
albumin,
good
enhancement,
rapid
excretion,
reliable
phases
comparable
classic
gadolinium
ethoxybenzyl
diethylenetriamine
pentaacetic
(Gd-EOB-DTPA)
in
vivo
liver
tumor
imaging.
Inhibition
experiments
confirmed
targeting
MnL6
is
mediated
by
organic
anion-transporting
polypeptides.
Language: Английский
Fluorinated 1,7-DO2A-Based Iron(II) Complexes as Sensitive 19F MRI Molecular Probes for Visualizing Renal Dysfunction in Living Mice
Lingxuan Li,
No information about this author
Chaoxian Chen,
No information about this author
Yifan Bu
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(26), P. 10827 - 10834
Published: June 17, 2024
Kidney
diseases
have
become
an
important
global
health
concern
due
to
their
high
incidence,
inefficient
diagnosis,
and
poor
prognosis.
Devising
direct
methods,
especially
imaging
means,
assess
renal
function
is
the
key
for
better
understanding
mechanisms
of
various
kidney
subsequent
development
effective
treatment.
Herein,
we
developed
a
fluorinated
ferrous
chelate-based
sensitive
probe,
1,7-DO2A-Fe(II)-F18
(Probe
1),
19F
magnetic
resonance
(MRI).
This
highly
probe
(containing
18
chemically
equivalent
atoms
with
fluorine
content
at
35
wt
%)
achieves
15-time
enhancement
in
signal
intensity
compared
fluorine-containing
ligand
alone
appropriately
regulated
relaxation
times
by
ion,
which
significantly
increases
sensitivity
reduces
acquisition
time.
Owing
its
aqueous
solubility,
biostability,
biocompatibility,
this
could
be
rapidly
cleared
kidneys,
provides
means
monitoring
dysfunction
via
MRI.
With
accomplish
vivo
impaired
caused
including
acute
injury,
unilateral
ureteral
obstruction,
fibrosis
different
stages.
Our
study
illustrates
promising
potential
Probe
1
real-time
visualization
dysfunction,
beneficial
study,
even
stratification
diseases.
Furthermore,
design
strategy
our
inspiring
more
high-performance
MRI
probes
biological
processes.
Language: Английский
New approaches to acute kidney injury
Sanjeev Noel,
No information about this author
R. Kapoor,
No information about this author
Hamid Rabb
No information about this author
et al.
Clinical Kidney Journal,
Journal Year:
2024,
Volume and Issue:
17(Supplement_2), P. 65 - 81
Published: Nov. 22, 2024
ABSTRACT
Acute
kidney
injury
(AKI)
is
a
common
and
serious
clinical
syndrome
that
involves
complex
interplay
between
different
cellular,
molecular,
metabolic
immunologic
mechanisms.
Elucidating
these
pathophysiologic
mechanisms
crucial
to
identify
novel
biomarkers
therapies.
Recent
innovative
methodologies
the
advancement
of
existing
technologies
has
accelerated
our
understanding
AKI
led
unexpected
new
therapeutic
candidates.
The
aim
this
review
introduce
update
reader
about
recent
developments
applying
in
omics,
imaging,
nanomedicine
artificial
intelligence
research,
plus
provide
examples
where
can
be
translated
improve
patient
care.
Language: Английский
One-Pot Fabrication of Kinetically Inert Ultrasmall Manganese(II) Chelate-Backboned Polymer Contrast Agents for High-Performance Magnetic Resonance Imaging
Nano Letters,
Journal Year:
2024,
Volume and Issue:
24(45), P. 14252 - 14262
Published: Oct. 14, 2024
Traditional
macromolecules
or
nanoscale
Mn2+
chelate-based
magnetic
resonance
imaging
(MRI)
contrast
agents
(CAs)
suffer
from
complicated
and
laborious
synthesis
processes,
relatively
low
kinetic
stability
T1
relaxivity,
limiting
their
clinical
applications.
Herein,
we
fabricated
a
series
of
kinetically
inert
chelate-backboned
polymers,
P(MnL-PEG),
through
facile
one-pot
polymerization
process.
Particularly,
P(MnL-PEG)-3
demonstrates
significantly
higher
relaxivity
23.9
Mn
mM–1
s–1
at
1.5
T
than
that
previously
reported
small
molecules
CAs.
Due
to
its
high
extended
blood
circulation,
hepatocyte-specific
uptake,
kidneys
metabolism,
presents
enhanced
in
vessel,
liver,
compared
Gd3+-based
CAs
(Gd-EOB-DTPA
Gd-DOTA)
dosage
0.05
mmol
Mn/Gd
kg–1
BW,
can
accurately
diagnose
orthotopic
H22
liver
tumors
vivo
animal
models.
We
anticipate
this
work
will
promote
the
development
clinically
relevant
MRI
Language: Английский